Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Microbiology (medical),Genetics,Applied Microbiology and Biotechnology,Immunology,Microbiology
Reference6 articles.
1. Derrien, M., Collado, M. C., Ben-Amor, K., Salminen, S. & de Vos, W. M. The mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Appl. Env. Microbiol. 74, 1646–1648 (2008). This article establishes A. muciniphila as a key member of the human microbiota.
2. Cani, P. D., Depommier, C., Derrien, M., Everard, A. & de Vos, W. M. Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms. Nat. Rev. Gastroenterol. Hepatol. 19, 625–637 (2022). A review article that describes the discovery of A. muciniphila and discusses its health benefits.
3. Desai, M. S. et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167, 1339–1353 (2016). This article describes the increased risk of experimental colitis due to mucin-degrading properties of A. muciniphila in low-fibre diets.
4. Schwabkey, Z. I. et al. Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment. Sci. Transl Med. 14, eabo3445 (2022). This paper describes a role for A. muciniphila in mucus degradation associated with neutropenic fever.
5. Chao, M. C., Abel, S., Davis, B. M. & Waldor, M. K. The design and analysis of transposon insertion sequencing experiments. Nat. Rev. Microbiol. 14, 119–128 (2016). A review article that summarizes the application of next generation sequencing of transposon insertions to track mutants in complex pools.